Articles

Browse our regulatory articles below or search through our archive.

 


 

HOW MD&M WEST ATTENDEES CAN OVERCOME REGULATORY CHALLENGES

by Arazy Group | Feb 07, 2017
Over the next three days, MedTech professionals will be heading to the 32nd annual MD&M West Conference. While it is important for them to define design techniques and development strategies, as well as leverage the latest breakthroughs in value-based product development, it is just as important to focus on overcoming regulatory challenges.

In order to sell a medical or in vitro diagnostic (IVD) device in a particular country, it must be registered with the local regulatory agency. But without the right expertise and tools, obtaining premarket approval for devices can be a challenge —  regardless of their level of risk, indications of use and technical specifications. And yet, the practice of regulatory affairs remains a fragmented, expensive and inefficient process that is managed manually, mostly through local distributors and consultants.

Regulatory intelligence and registration tool LICENSALE.COM is transforming the way medical and IVD device registration is managed. Being rapidly implemented all over the world, the cloud-based solution can be customized to fit a MedTech firm’s specific needs, so it can best meet its business objectives.

With LICENSALE.COM MedTech manufacturers can:

• Reduce regulatory costs by as much as 50% and get approvals for a fixed price
• Expedite time-to-market by 100%
• Quickly gain access to 100+ markets across the globe and even process multiple market clearance applications simultaneously
• Easily control and trace past, present and future registration processes
• Retain ownership of licenses

Through LICENSALE.COM, global radiation therapy giant Elekta was able to obtain regulatory approval for 78 products in 16 countries – all in less than a year. If you would like to experience this level of success, contact us today, and we’ll discuss how to transform your regulatory pathway.





 
 
 
 
Category:
  • Blog
Tags:
latest news
  • Apr 24 2017
    70+ CLASS I DEVICES NOW EXEMPT FROM 510(K) REQUIREMENTS

    The US Food and Drug Administration (FDA) has identified a list of over 70 class I devices that are now exempt from premarket notification requirements....

    Read More
  • Apr 19 2017
    REGULATORY UPDATE: ETGAR MEDICAL INSTRUMENTS

    USA: Etgar Medical Instruments' Dental Implants System was approved for sale with LICENSALE.COM®. ...

    Read More
  • Apr 19 2017
    RUSSIAN REGULATORS ISSUE REQUIREMENTS FOR IVD & MEDICAL DEVICE TECHNICAL FILE SUBMISSIONS

    The Russian Ministry of Health has introduced a new regulation that clarifies the official requirements for in vitro diagnostic (IVD) & medical device technical file submissions. ...

    Read More
  • Apr 6 2017
    REMINDER: ARAZY GROUP CAN HELP REGISTER MEDICAL DEVICES IN BRAZIL IN JUST 7-9 MONTHS

    As a member of ABIMED (the Brazilian Association of Industry of High Technology Medical and Hospital Equipments, Products and Suppliers), Arazy Group can help medical device manufacturers register their products in Brazil within seven to nine months. ...

    Read More
  • Apr 4 2017
    ARAZY GROUP OFFERS QMS UPGRADE TO ISO 13485:2016 STANDARD

    In line with its commitment to making safe and effective IVD and medical devices available worldwide, regulatory affairs firm Arazy Group Consultants Inc. is assisting MedTech manufacturers in meeting the deadline to upgrade their quality management syste...

    Read More

VANCOUVER OFFICE

  • Phone +1 604.681.6888
  • Fax +1 604.681.6822
  • info@arazygroup.com
  •  
  • #350-1333 Johnston Street
  • Pier 32, Granville Island
  • Vancouver, British Columbia
  • Canada V6H 3R9

BACK TO TOP